CST1 and breast cancer: Currently, researchers agreed that alterations of gene expression patterns were crucial for PTC pathogenesis [6, 7, 8, 9], and this study identified CST1 (cystatin 1) as an oncogene to facilitate PTC development, which was inconsistent with previous studies in breast cancer [15] and GC cells [14].